A randomized, double-blind, placebo-controlled trial of a selective COX-2 inhibitor, GW406381, in patients with postherpetic neuralgia.
Shackelford, Steve
A randomized, double-blind, placebo-controlled trial of a selective COX-2 inhibitor, GW406381, in patients with postherpetic neuralgia. [electronic resource] - The journal of pain Jun 2009 - 654-60 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1528-8447
10.1016/j.jpain.2009.01.328 doi
Aged
Cyclooxygenase 2 Inhibitors--administration & dosage
Dose-Response Relationship, Drug
Double-Blind Method
Female
Humans
Male
Neuralgia, Postherpetic--drug therapy
Pain Measurement
Pyrazoles--administration & dosage
Pyridazines--administration & dosage
Treatment Outcome
A randomized, double-blind, placebo-controlled trial of a selective COX-2 inhibitor, GW406381, in patients with postherpetic neuralgia. [electronic resource] - The journal of pain Jun 2009 - 654-60 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1528-8447
10.1016/j.jpain.2009.01.328 doi
Aged
Cyclooxygenase 2 Inhibitors--administration & dosage
Dose-Response Relationship, Drug
Double-Blind Method
Female
Humans
Male
Neuralgia, Postherpetic--drug therapy
Pain Measurement
Pyrazoles--administration & dosage
Pyridazines--administration & dosage
Treatment Outcome